[1]Siegl C, Prusty B K, Karunakaran K, et al. Tumor suppressor p53 alters host cell metabolism to limit Chlamydia trachomatis infection[J].Cell Rep,2014,9(3):918 [2]Vousden K H, Ryan K M.p53 and metabolism[J].Nat Rev Cancer,2009,9(10):691 [3]Prusty B K, B?hme L, Bergmann B, et al. Imbalanced oxidative stress causes chlamydial persistence during non-productive human herpes virus co-infection[J]. PLoS One,2012,7(10):e47427 [4]Tipples G, Mcclarty G. The obligate intracellular bacterium Chlamydia trachomatis is auxotrophic for three of the four ribonucleoside triphosphates[J].Mol Microbiol,1993,8(6):1105 [5]Eisenreich W, Heesemann J, Rudel T, et al. Metabolic host responses to infection by intracellular bacterial pathogens[J].Front Cell Infect Microbiol,2013,3:24 [6]Subbarayal P, Karunakaran K, Winkler A C, et al. EphrinA2 receptor (EphA2) is an invasion and intracellular signaling receptor for Chlamydia trachomatis[J]. PLoS Pathog,2015,11(4):e1004846 [7]Nagata N, Akiyama J, Marusawa H, et al. Enhanced expression of activation-induced cytidine deaminase in human gastric mucosa infected by Helicobacter pylori and its decrease following eradication[J].J Gastroenterol,2014,49(3):427 [8]Rajalingam K, Sharma M, Lohmann C, et al. Mcl-1 is a key regulator of apoptosis resistance in Chlamydia trachomatis-infected cells[J].PLoS One,2008,3(9):e3102 [9]Verbeke P, Welter-Stahl L, Ying S, et al. Recruitment of BAD by the chlamydia trachomatis vacuole correlates with host-cell survival[J].PLoS Pathog, 2006,2(5):e45 [10]Lin Y G, Han L Y, Kamat A A, et al. EphA2 overexpression is associated with angiogenesis in ovarian Cancer[J].Cancer,2007,109(2):332 [11]Patel A L, Chen X, Wood S T, et al. Activation of epidermal growth factor receptor is required for Chlamydia trachomatis development[J].BMC Microbiol,2014,14:277 [12]Wade M, Li Y C, Wahl G M. MDM2, MDMX and p53 in oncogenesis and Cancer therapy[J].Nat Rev Cancer,2013,13(2):83 [13]González E, Rother M, Kerr M C, et al. Chlamydia infection depends on a functional MDM2-p53 axis[J].Nat Commun,2014,5:5201 [14]Opferman J T, Letai A, Beard C, et al. Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1[J].Nature,2003,426(6967):671 [15]Opferman J T, Iwasaki H, Ong C C, et al. Obligate role of anti-apoptotic MCL-1 in the survival of hematopoietic stem cells[J].Science,2005,307(5712):1101 [16]Ying S, Christian J G, Paschen S A, et al. Chlamydia trachomatis can protect host cells against apoptosis in the absence of cellular Inhibitor of Apoptosis Proteins and Mcl-1[J].Microbes Infect,2008,10(1):97 [17]Maurer U, Charvet C, Wagman A S, et al. Glycogen synthase kinase-3 regulates mitochondrial outer membrane permeabilization and apoptosis by destabilization of MCL-1[J].Mol Cell,2006,21(6):749 [18]Stanley M.Pathology and epidemiology of HPV infection in females[J].Gynecol Oncol,2010,117(2, 1):S5 [19]Chaturvedi A K, Gaydos C A, Agreda P, et al. Chlamydia pneumoniae infection and risk for lung Cancer[J].Cancer Epidemiol Biomarkers Prev,2010,19(6):1498 [20]Smith J S, Bosetti C, Mu?oz N, et al. Chlamydia trachomatis and invasive cervical Cancer: a pooled analysis of the IARC multicentric case-control study[J].Int J Cancer,2004,111(3):431 [21]Smith J S, Mu?oz N, Herrero R, et al. Evidence for chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical Cancer in Brazil and the Philippines[J].J Infect Dis,2002,185(3):324 [22]Koskela P, Anttila T, Bj?rge T, et al. Chlamydia trachomatis infection as a risk factor for invasive cervical Cancer[J].Int J Cancer,2000,85(1):35 [23]Safaeian M, Quint K, Schiffman M, et al. Chlamydia trachomatis and risk of prevalent and incident cervical premalignancy in a population-based cohort[J].J Natl Cancer Inst,2010,102(23):1794 [24]Siegl C, Rudel T. Modulation of p53 during bacterial infections[J].Nat Rev Microbiol,2015,13(12):741 [25]Chumduri C, Gurumurthy R K, Zadora P K, et al. Chlamydia infection promotes host DNA damage and proliferation but impairs the DNA damage response[J].Cell Host Microbe,2013,13(6):746
作者简介 任杰(1987-),女,博士在读,研究方向:皮肤性病学;通信作者:刘全忠,E-mail: liuquanzhong@medmail.com.cn。